Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.
Georgios KokkotisKonstantina KitsouIoannis XynogalasVana SpoulouGkikas MagiorkinisIoannis TrontzasPanagiotis TrontzasGaryphallia PoulakouKonstantinos SyrigosGiorgos BamiasPublished in: Alimentary pharmacology & therapeutics (2021)
TNF-α inhibitors are associated with a lower probability of hospitalisation and severe COVID-19 when compared to any other treatment for an underlying inflammatory disease.